AL
AlzChem Group AG
ALZCF · OTC
$184.90 +0.00% (+$0.00)
Market Cap 1.67B €
P/E Ratio 24.62x
Div. Yield 1.34%
ROE 26.10%
Bulios Fair Price
$159.54
13.7% downside
Current Price
$184.9
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ALZCF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
23 /100
Expensive PEG 1.52x
P/E 24.62x
P/B 6.19x
Growth
73 /100
Growing Book val. growth 21.17%
EPS growth 28.28%
Rev. growth 1.20%
Profitability
67 /100
Strong Op. margin 15.21%
Gross margin 14.23%
FCF margin 3.23%
Quality
91 /100
Excellent ROA 10.07%
ROIC 11.26%
Asset turnover 0.86x
Debt
100 /100
Low Int. coverage 42.15x
Debt/Equity 0.33x
Net debt/EBITDA 0.21x
Stability
80 /100
Stable EPS volatility 23.11%
Beta 0.58x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALZCF
Online
Sector
Basic Materials
Industry
Chemicals
CEO
Andreas Niedermaier
Employees
1,765
Headquarters
Trostberg
Upcoming events
29 OCT
Earnings
Upcoming earnings report